Amber Uppal

Doctor of Medicine,  Toronto General - University Health Network 

Location: India

Consulting Services

Data Science-Bioinformatics Journal Manuscript Case Consulting

Areas Of Interest

Excitatory Postsynaptic Current Symptomatic Parkinsonism Training Group, Sensitivity Neisseria mucosa Fibronectin Receptor Cytochrome C 2 FMLP Receptor Photocoagulations TATA-Box-Binding Protein Kidney Medullas Cytidine Diphosphate Diglycerides Sequences, E-Box Anatomies E-Box Motifs Asialoorosomucoid Receptors gamma, DGK Colon, Ascending Angle Class II, Division 2 Aminopyrine N Demethylase Tropicamide Monofree Beclovent Complement, C1r Diaries Cross Transfusion, Intrauterine Medication Development Cerebri, Crura Research, Action Protein Transport Polychlorotriphenyl Compounds Ulcer, Mouth Mastocytosis, Indolent Systemic

Professional Narrative

Dr. Amber Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Harvard Med 1998
Medical Writer, Amgen 2010

Education

Director Medicine, Harvard Medical School 1994
Master of Science in physician assistant, Perelman School of Medicine 2000

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :